Quidel JPM Healthcare Conference Day 3: Quantum-Si, Olink, Exact Sciences, Bio-Techne, Opko Health, More Highlights of the third day included Quantum-Si's plans for its protein sequencing platform and strategic initiatives from Opko's BioReference Laboratories. Quidel Preliminary Q4 Revenues Drop 21 Percent, Beat Estimates For the fourth quarter of 2021, the firm expects COVID-19 revenues of approximately $510 million and total revenues of $633 million to $637 million. GenomeWeb Index Falls 6 Percent in November as Emergence of Omicron Spooks Markets The GenomeWeb Index underperformed the Dow Jones, the Nasdaq, and the Nasdaq Biotechnology Index last month. Quidel Q3 Revenues Up 7 Percent, Beat Analysts' Estimate Quidel's molecular diagnostic solutions business revenues fell 13 percent due in part to a decline in sales of Lyra PCR assays for COVID-19 diagnosis. Quidel Preliminary Q3 Revenues Rise, Easily Beat Analysts' Estimate Quidel expects approximately $406.0 million in COVID-19 revenues compared with $375.7 million a year ago. Oct 1, 2021 GenomeWeb Index Takes 7 Percent Tumble in September Aug 5, 2021 Quidel Q2 Revenues Dip 12 Percent; Misses on Revenues and EPS Estimates Jul 26, 2021 Quidel, Beckman Coulter Settle Legal Dispute Over Cardiac Immunoassay Business Jul 19, 2021 OraSure Stock Ticks Up on Rumor of Declined Quidel Acquisition Offer Jul 12, 2021 Quidel Nabs CE Mark for Savanna Analyzer, Respiratory Panel Jul 7, 2021 Quidel Recalls Lyra SARS-CoV-2 Test Due to Potential False Negative Results Jun 1, 2021 GenomeWeb Index Down in May as NanoString Technologies Falls 30 Percent From April Apr 23, 2021 Quidel Preliminary Q1 Revenues Double But Fall Far Short of Expectations Mar 10, 2021 Quidel Guides for Revenues Below Street Estimate, Citing Softening SARS-CoV-2 Test Demand Mar 2, 2021 Quidel Stock Plunges in February as GenomeWeb Index Falls 3 Percent Feb 19, 2021 Quidel Reports Delay in OTC COVID-19 Antigen Test Claims, Pours Cold Water on M&A Rumors Premium Feb 18, 2021 Quidel Q4 Revenues Increase Sharply on COVID-19 Sales, Beat EPS Estimates Feb 1, 2021 Fulgent Genetics Soars in January as GenomeWeb Index Begins 2021 up 10 Percent Jan 13, 2021 At JP Morgan Conference, Quidel CEO Discusses Plan to Enter OTC Infectious Disease Test Market Jan 7, 2021 Quidel Preliminary Q4 Revenues Up Fivefold Dec 23, 2020 Quidel Gets EUA for Rapid, Extraction-Free COVID-19 MDx on Solana System Dec 1, 2020 Veracyte, Twist Bioscience Lead November GenomeWeb Index on Strong Earnings Growth Oct 30, 2020 Quidel Expects SARS-CoV-2 Testing Demand to Continue 'Through 2022, and Beyond' Premium Oct 29, 2020 Quidel Q3 Revenues More Than Triple, Beat Analyst Expectations Oct 1, 2020 Quidel Releases Preliminary Q3 Results, Partners with Biodesix for Big Ten Surveillance Load More Breaking News In Ongoing False Advertising Suit, Judge Allows Natera Counterclaims Against Guardant Health Centogene Strikes Rare Disease Target Discovery Deal With Insilico Medicine Dilated Cardiomyopathy Gene Mutations Point to Possible Therapeutic Strategy Ginkgo Bioworks Acquires Massachusetts COVID-19 Testing Firm Mainz Biomed Taps DCN Dx to Aid European Study of Enhanced ColoAlert Assay Parse Biosciences Partners With Research Instruments for Southeast Asia Distribution The Scan Transplant Tests Edited Pig Kidneys The Associated Press reports a University of Alabama-Birmingham team transplanted genetically modified pig kidneys into a brain-dead human patient. UK Changes Some Gene-Edited Crop Rules A new law may enable gene-edited crops to be sold in the UK within about five years, New Scientist says. Pill Works Against Omicron in Lab Pfizer's antiviral pill to treat SARS-CoV-2 appears to work against the Omicron variant, the Wall Street Journal reports. Nature Papers Find Genetic Risk Factor for Smell, Taste Loss in COVID-19; Analyze TB Granulomas In Nature this week: genome-wide association study find locus linked to the risk COVID-19 patients losing their sense of taste or smell, and more.